LORI TURNER: Open Payments
NPI 1649770231 · GRIFFITH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,334 in 32 payments from 11 companies in 2025. Trend: 2023 $801 · 2024 $414 · 2025 $1,334
Food & beverage: $1,334
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $334 |
| Novo Nordisk Inc | 3 | $250 |
| Otsuka America Pharmaceutical, Inc. | 6 | $218 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $142 |
| Lilly USA, LLC | 2 | $127 |
| Exact Sciences Corporation | 5 | $101 |
| Almatica Pharma LLC | 2 | $43 |
| PFIZER INC. | 1 | $40 |
| HARMONY BIOSCIENCES LLC | 1 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
Products named: Ozempic, REXULTI, AIRSUPRA, Kerendia, BREZTRI, MOUNJARO, Cologuard Collection Kit, LOREEV XR.
Industry payments across IN — which companies pay providers there.
